A Breakthrough T1D Venture, LLC, an impact investment fund focused on accelerating life-changing solutions to treat, prevent, and ultimately cure type 1 diabetes, today announced Teresa Foy, Ph.D., ...

Grant will strengthen insurance and Medicaid navigation and continuity of care for adults living with T1D ...

A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...

Sana Biotechnology's favorable Phase 1 trial could rapidly re-rate the stock even higher, especially since it targets a ...

Written by an international panel and endorsed by several professional societies, a new consensus statement provides guidance ...

The grant supports Breakthrough T1D's partnership with Touro University California's Mobile Diabetes Education Center VALLEJO, Calif., Nov. 10, 2025 /PRNewswire/ -- Breakthrough T1D has been selected ...

Lexicon Pharmaceuticals, Inc. is downgraded to Hold due to repeated FDA rejections of ZYNQUISTA for T1D and catalysts. Read more on LXRX stock here.

“This is an exciting time for T1D cure research,” said Phil Shaw, Executive Director at JDCA. “In the fourteen years I’ve been conducting this work, we are witnessing a fundamental shift in cure ...

FDA grants Priority Review to teplizumab for patients aged 1 to 7 years with stage 2 type 1 diabetes to delay stage 3 onset.

Sanofi SNY announced that the European Commission has approved Teizeild (teplizumab) to delay the onset of stage 3 type 1 ...

Living with Type 1 diabetes (T1D) is a 24/7 balancing act. Every meal, activity, and decision is shaped by the need to manage blood sugar and avoid dangerous highs and lows. “Staying in range” is only ...

The Breakthrough T1D Play program is a medical research charity raising money for critical research into diabetes, one of the biggest causes of death in the U.S. And this week, gaming pioneer Will ...